Olympic runner Semenya loses fight over testosterone rules
GENEVA — The sports world’s highest court ruled Wednesday that Olympic champion Caster Semenya and other female runners like her with unusually high testosterone must take medication to reduce their levels of the male sex hormone if they want to compete in certain events — a landmark decision with far-reaching ramifications for other women’s sports.
In a 2-1 ruling, the Court of Arbitration for Sport upheld proposed rules issued by track’s governing body, the IAAF, saying that they are discriminatory but that “such discrimination is a necessary, reasonable and proportionate means” of “preserving the integrity of female athletics.”
The IAAF argued that high, naturally occurring levels of testosterone in athletes like Semenya with “intersex” characteristics that don’t conform to standard definitions of male and female give them an unfair competitive advantage, and it decreed a maximum level for females.